University of Edinburgh Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Imperial College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
"monoclonal" AND "antibod…×
10 miles

Cancer / Oncology (monoclonal antibodies) PhD Projects, Programs & Scholarships

We have 6 Cancer / Oncology (monoclonal antibodies) PhD Projects, Programs & Scholarships

  • "monoclonal" AND "antibodies" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 6 of 6
  Bispecific monoclonal antibodies for cancer immunotherapy
  Prof W Bodmer, Prof P McHugh
Application Deadline: 10 January 2020

Funding Type

PhD Type

THE PROJECT. Monoclonal antibodies (MCAs) are now widely used for cancer therapy. DNA recombinant technology enables the production of MCAs that target cancer specific determinants and immune cells, attracting them to the cancer cells and so killing them.
  Chimeric Antigen B Cell (CAR B Cell) Therapy for Targeted Therapeutic and Prophylactic Vaccination
  Prof L Seymour, Prof S Draper
Application Deadline: 10 January 2020

Funding Type

PhD Type

Lead supervisor. Prof Len Seymour, Department of Oncology, University of Oxford. Co-supervisor. Prof Simon Draper, Jenner Institute, University of Oxford.
  Antibody-drug conjugates (ADCs) for the treatment of solid tumours
  Dr S Karagiannis, Prof J Downward
Application Deadline: 29 November 2019

Funding Type

PhD Type

An Antibody-Drug Conjugate (ADC) comprises an antibody targeted toward a tumour cell surface antigen, coupled through a chemical linker to a highly-cytotoxic drug.
  (MRC DTP) New strategies for immuno-PET radiochemistry
  Dr A McMahon, Dr M Fairclough, Prof K Williams
Application Deadline: 15 November 2019

Funding Type

PhD Type

Aims. To enhance immunoPET availability through. 1. Significant reduction in antibody usage. 2. Development of a secondary [18F]affibody approach applicable to all mAbs.
  (BBSRC DTP) Development of anti-cancer agents and biomarkers that target intrinsically disordered regions of transcription factors and protein kinases
  Prof J Waltho, Dr A Almond
Application Deadline: 31 January 2020

Funding Type

PhD Type

The controlled manipulation of transcription factors, protein kinases and protein phosphatases is central to improving our understanding of cellular processes and, importantly, in the development of next-generation therapeutics for a variety of cancers.
  Improving the success of antibody based drugs by characterising the patients’ immune system
  Dr A Watts
Application Deadline: 17 November 2019

Funding Type

PhD Type

The University of Bath, in conjunction with Qualasept Ltd, is inviting applications for a fully-funded PhD studentship. SUPERVISORY TEAM.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.